Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Derfuss

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Neurology|November 15, 2011
Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MSJ Kuhle, R Gosert, R Bühler, et al.
Journal of Neuroimmunology|September 11, 2007
CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesionsM Krumbholz, D Theil, F Steinmeyer, et al.
European Journal of Neurology|January 21, 2018
ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosisX Montalban, R Gold, A J Thompson, et al.
Neurology|July 29, 2011
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitisA K Pröbstel, K Dornmair, R Bittner, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 15, 2015
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre studyJ Kuhle, G Disanto, R Dobson, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Neurology|November 15, 2011
Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MSJ Kuhle, R Gosert, R Bühler, et al.
Journal of Neuroimmunology|September 11, 2007
CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesionsM Krumbholz, D Theil, F Steinmeyer, et al.
European Journal of Neurology|January 21, 2018
ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosisX Montalban, R Gold, A J Thompson, et al.
Neurology|July 29, 2011
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitisA K Pröbstel, K Dornmair, R Bittner, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 15, 2015
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre studyJ Kuhle, G Disanto, R Dobson, et al.
Pageof 3